Back to search
Ascending Aortic Aneurysm
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Ascending Aortic Aneurysm trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Ascending Aortic Aneurysm trials you may qualify forTo assess the safety and effectiveness of the ASG device in the treatment of de novo Type A aortic dissections.
Multicenter, global, prospective, non-randomized, interventional, post-market trial. All subjects enrolled will receive an Abbott Valved Graft device.
This study is a single-arm, open-label, multi-center clinical trial evaluating the safety and efficacy of endovascular treatment for retrograde dissection invol…
This study investigates outcomes after hemiarch repair in patients with chronic ascending aortic disease. The patients will be divided into two groups according…
According to the literature, presepsin was recommended not only as an effective indicator in the diagnosis of sepsis in intensive care units, but also as a reli…
The biomechanical properties of the aorta are currently poorly understood. A better understanding would optimize surgical indications and monitoring techniques…
The purpose of this study is to assess the role endovascular therapy to treat aortic disease involving the ascending aorta, the aortic arch, and the visceral se…
The primary objective of ARISE II is to assess the safety and effectiveness of the GORE® Ascending Stent Graft device in the treatment of lesions involving the…